Note: This is an open invitation, and may be forwarded to interested parties.
There are a myriad of challenges and uncertainties associated with the emergence of Zika virus (ZIKV) infection in Central/South America and the Caribbean.
The following topics will be presented and discussed:
- The evolving epidemiology of ZIKV infections
- Diagnostic recommendations and their associated challenges
- Challenges associated with managing a pregnant woman at risk of or infected with Zika virus
- The etiology of potential ZIKV complications, especially microcephaly/congenital birth defects and Guillain-Barre Syndrome
- Efforts to develop a Zika virus vaccine
- Mosquito control efforts/personal protection measures
Note: This session will contain similar information to that presented at PHOL Microbiology Rounds on February 24, 2016. Relevant updates will be included.
DISCLAIMER: The opinions expressed by speakers and moderators do not necessarily reflect the official policies or views of Public Health Ontario, nor does the mention of trade names, commercial practices, or organizations imply endorsement by Public Health Ontario.
Presenters: Dr. Kellie Murphy, Dr. Doug Sider and Dr. Jonathan Gubbay
Dr. Kellie Murphy completed her obstetrical residency program at Albert Einstein College of Medicine in New York City in 1995. She then completed a Maternal-Fetal Medicine fellowship program and a Master of Epidemiology at Columbia Presbyterian Medical Center and School of Public Health in New York. In July 1998, she joined the department of Obstetrics and Gynecology at the University of Toronto where she is currently an Associate Professor, based out of Mount Sinai Hospital.
Dr. Doug Sider is a public health and preventive medicine specialist who serves as Medical Director for Communicable Disease Prevention and Control at Public Health Ontario, where he has an operational and research focus on vector-borne diseases. He has had extensive experience at the local public health unit level; has co-chaired the Provincial Infectious Diseases Advisory Committee from 2005-2009; and is an assistant professor in McMaster University’s Department of Clinical Epidemiology and Biostatistics.
Dr. Jonathan Gubbay is a medical microbiologist responsible for overseeing virus detection, respiratory bacteriology and arboviruses at PHO’s Laboratory, and is the laboratory lead for emerging viral pathogens. He is an assistant professor in the Departments of Laboratory Medicine and Pathobiology and Pediatrics at the University of Toronto and part-time staff physician in the Division of Infectious Diseases, The Hospital for Sick Children. He has a research interest in the molecular epidemiology and diagnosis of respiratory viral infections and the emergence of antiviral resistance.
Public Health Ontario Grand Rounds are approved for continuing medical education from the Royal College of Physicians and Surgeons.
PHO Grand Rounds are also approved by Council of Professional Experience for professional development hours (PDHs) for members of the Canadian Institute of Public Health Inspectors (CIPHI).
For more information, contact firstname.lastname@example.org.
Stay up-to-date on upcoming events and calls for abstracts by visiting our calendar
If you have submissions, or questions or comments about the items above, send them to email@example.com.
Public Health Ontario is committed to complying with the Accessibility for Ontarians with Disabilities Act (AODA).
If you require accommodations to participate in this event, please contact 647-260-7100